Health

Generic Drugs Market Outlook – Patent Expiries to Drive Future Growth

Netscribes, Inc. launches a report on Generic Drugs Market in India 2017 covering a market with strong growth potential. It is a part of Netscribes’ Healthcare Industry Series.
( PR4US.com | Press Release | 2017-09-13 23:11:39 )
Mumbai, India – September 13, 2017 – Global market intelligence firm, Netscribes, Inc. released its latest report on the ‘Generic Drugs Market in India 2017’ (https://www.researchonindia.com/generic-drugs-market-in-india-2017.html). The report states that the large number of drug patents slated to expire in the next few years will lead to the introduction of several new generics in the market.

Netscribes’ latest market research report titled Generic Drugs Market in India 2017 covers the current and future state of the generics market in the country. Demand for generics is expected to increase as patients shift from the more expensive branded drugs to the lower priced generics. Various initiatives from the government to increase the usage of generics instead of branded drugs, wherever possible, are also helping in the growth of the market. Setting up of a large number of Jan Aushadhi stores is making generics more accessible. Moreover, government’s proposal in Jul 2016 whereby physicians would have to mention generic names of drugs instead of names of branded drugs is expected to further boost the market.

Generic drug manufacturers operating in India have a distinct cost advantage when it comes to manufacturing. The low manufacturing costs in the country enable Indian companies to manufacture generic drugs at costs lower than the cost at which companies operating in regulated markets manufacture. Consequently, this has created a huge export opportunity for Indian companies. The US is one of the largest importers of generic drugs from India. Recently, regulatory warnings from foreign regulatory bodies such as the USFDA regarding lapses in product quality and for not adhering to stipulated manufacturing standards have led to a negative perception of generics manufactured in India. The industry, however, realizes the importance of these export markets and is taking remedial steps to ensure that such negative perceptions are removed.

Customizations Available
With the given market data, Research on India offers customizations according to specific needs. Write to us at support@researchonindia.com

For more details on the content of each report and ordering information please contact:

Phone:+91 33 4027 6243/6222; +91 33 4027 6200/6207; +91 22 4098 7600
E-Mail: support@researchonindia.com ; info@netscribes.com

About Netscribes

Netscribes (www.netscribes.com) is a global market intelligence and content management firm with services across the research and information value chain. Venture-funded by US and Singapore private equity firms, the company provides tactical and actionable insights to its clients and enables effective decision-making and strategic implementation.

For more information please write to info@netscribes.com


Press Information


Published by

Ankita Basu

+91 33 4027 6243
Office No. 504, 5th Floor, Lodha Supremus, Lower Parel
400012 Mumbai - India
https://www.netscribes.com/

Contact Ankita Basu


 

 

 

 

 

 

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact PR4US. We will not be able to assist you. PR4US disclaims the content included in this release.
Preparing for PR: Five Hot Tips for Startups
PR Fundamentals for Startups - MaRS Best Practices
Public Relations 101
Public Relations Strategy in Our World Today!
Introduction to Public Relations
Trends in Communicating
How to Do Marketing/PR on a Budget - CoInvent Startup Summit 2014 New York
Monika Dixon Shares PR Tips